Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice

Figure 6

Dynamic variations of CTC molecular profile in still living patients at T1 and T2 evaluation with respect to clinical outcomes and therapeutic response (SD: stable disease, PD: progression disease).